Literature DB >> 22814623

A ventricular assist device as a bridge to recovery, decision making, or transplantation in patients with advanced cardiac failure.

Siyamek Neragi-Miandoab1.   

Abstract

Despite many advances in the management of patients with heart failure, acute cardiogenic shock and progressive congestive heart failure remain serious problems with dismal prognoses. Both temporary and permanent mechanical support has been gaining wide clinical application in this patient population. Although mechanical circulatory support technology is rapidly evolving, this approach is associated with multiple issues such as the optimal duration of temporary support, ideal timing to bridge these patients to a long-term device, and selection of the right device for the right patient. The currently available devices are categorized into two major groups: temporary and long-term devices (including destination therapy). Heart failure is a dynamic condition, and the therapeutic approach may need to be modified depending on the patient's condition. Furthermore, the patient's preexisting morbidity, age, socioeconomic status, and family support are confounding factors that need to be considered when making such decisions. Clinical trials including prospective studies, as well as meticulous analysis of existing data, may help develop universal guidelines to select the right device. This manuscript will review the most widely used ventricular assist devices.

Entities:  

Mesh:

Year:  2012        PMID: 22814623     DOI: 10.1007/s00595-012-0256-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  101 in total

1.  Mechanical reliability of the Jarvik 2000 Heart.

Authors:  Michael P Siegenthaler; O H Frazier; Friedhelm Beyersdorf; Jürgen Martin; Hillel Laks; John Elefteriades; Asghar Khaghani; Ulf Kjellman; Bansi Koul; John Pepper; Robert Jarvik; Stephen Westaby
Journal:  Ann Thorac Surg       Date:  2006-05       Impact factor: 4.330

2.  Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report--2004.

Authors:  Mario C Deng; Leah B Edwards; Marshall I Hertz; Amanda W Rowe; Berkeley M Keck; Robert Kormos; David C Naftel; James K Kirklin
Journal:  J Heart Lung Transplant       Date:  2004-09       Impact factor: 10.247

3.  Impella 2.5.

Authors:  Daniel H Raess; David M Weber
Journal:  J Cardiovasc Transl Res       Date:  2009-04-02       Impact factor: 4.132

4.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

Authors:  Panos E Vardas; Angelo Auricchio; Jean-Jacques Blanc; Jean-Claude Daubert; Helmut Drexler; Hugo Ector; Maurizio Gasparini; Cecilia Linde; Francisco Bello Morgado; Ali Oto; Richard Sutton; Maria Trusz-Gluza
Journal:  Eur Heart J       Date:  2007-08-28       Impact factor: 29.983

5.  First experiences with the HeartWare ventricular assist system in children.

Authors:  Oliver Miera; Evgenij V Potapov; Matthias Redlin; Alexander Stepanenko; Felix Berger; Roland Hetzer; Michael Hübler
Journal:  Ann Thorac Surg       Date:  2011-04       Impact factor: 4.330

6.  A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH.

Authors:  P Urban; J C Stauffer; D Bleed; N Khatchatrian; W Amann; O Bertel; M van den Brand; N Danchin; U Kaufmann; B Meier; J Machecourt; M Pfisterer
Journal:  Eur Heart J       Date:  1999-07       Impact factor: 29.983

7.  The UNOS OPTN Waiting List and Donor Registry: 1988-1996.

Authors:  A M Harper; J D Rosendale
Journal:  Clin Transpl       Date:  1996

8.  Bridge to transplantation with the TandemHeart: bending the indications in a chronic aortic dissection patient with postcardiotomy shock.

Authors:  Stephane Reverdin; Igor D Gregoric; Biswajit Kar; Pranav Loyalka; Mark C Bieniarz; Scott A LeMaire; Joseph S Coselli; O H Frazier
Journal:  Tex Heart Inst J       Date:  2008

9.  The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience.

Authors:  Pascal Vranckx; Emanuele Meliga; Peter P T De Jaegere; Martin Van den Ent; Evelyn S Regar; Patrick W Serruys
Journal:  EuroIntervention       Date:  2008-11       Impact factor: 6.534

10.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Authors:  Melchior Seyfarth; Dirk Sibbing; Iris Bauer; Georg Fröhlich; Lorenz Bott-Flügel; Robert Byrne; Josef Dirschinger; Adnan Kastrati; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  2 in total

Review 1.  Current status of third-generation implantable left ventricular assist devices in Japan, Duraheart and HeartWare.

Authors:  Yoshiki Sawa
Journal:  Surg Today       Date:  2014-08-21       Impact factor: 2.549

2.  Early thrombus formation in patient with HeartWare left ventricular assist device presenting with acute heart failure.

Authors:  Mustafa Ucar; Mustafa Serkan Karakas; Murat Bayrak; Refik Emre Altekin; Umut Koksel; Omer Bayezid
Journal:  J Saudi Heart Assoc       Date:  2015-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.